Pfizer is proud to join sustainable development leaders from around the world as an Innovation Partner for the inaugural Devex World 2016 conference, taking place Tuesday, June 14 in Washington D.C. As part of our support for the event, Caroline Roan, Vice President of Pfizer Corporate Responsibility, will speak at the conference about Pfizer’s partnership with the United Nations Foundation in support of the Global Goals.
At Pfizer, we believe the cost of prescription medicines should never stand in the way of an individual’s ability to treat his or her health conditions. That’s why – for more than 25 years – we have empowered patients in need with assistance and information so they can get access to the Pfizer medicines prescribed by their doctor. Today, assistance is provided through Pfizer RxPathways® in the United States (including Puerto Rico and the US Virgin Islands).
In 2015, Pfizer's greenhouse gas emissions reduction goal was recognized as a Science Based Target by the initiative led by the Carbon Disclosure Project, the UN Global Compact, the World Resources Institute and World Wildlife Fund. This recognizes that Pfizer has established targets consistent with the level of decarbonization required by science to limit global warming to less than 2°C compared to pre-industrial temperatures.
Building on the successful achievements of Pfizer’s carbon emission reduction and green chemistry programs, we are working to contribute meaningfully to global efforts to reduce human impact on the environment.
Throughout the lifecycle of our products, our aspiration is to further reduce our carbon footprint and increase energy efficiency, decrease dependence on limited resources and reduce waste in order to help ensure a sustainable future for our patients, our global community and our company.
The International Trachoma Initiative is a partnership co-founded by Pfizer in 1998 with the goal of eliminating trachoma, the world’s leading cause of preventable blindness. As of this year, Pfizer, working as part of ITI, has distributed 500 million doses of an antibiotic used to treat the disease, and the Initiative has treated more than 100 million people suffering from trachoma.
Yesterday, Pfizer released its 2015 integrated annual review, an in-depth look into the company’s financial, social and environmental performance, as told through the voices of Pfizer colleagues. In short videos and testimonials, Pfizer scientists, researchers and business leaders share how they are working toward measurable change for people whose quality of life is affected by poor health or health risks.
Every year the National Health Service loses a staggering £950m because of missed appointments, or DNAs (did not attends) – no-shows who fail to cancel their appointments. Twelve million GP appointments are missed at a cost of £162m and 7.1m hospital appointments at a cost of £788m.
June 16th, 2015 /3BL Media/ - Americans suffer 1.5 million heart attacks and strokes each year, and cardiovascular disease is the leading cause of death in the United States. According to the U.S. Centers for Disease Control and Prevention (CDC), African-American men are 25 percent more likely to die from heart disease, compared to non-Hispanic white men. To help address this health disparity, the CDC Foundation is partnering with Pfizer and Quest Diagnostics to launch the Million Hearts® “Healthy is Strong” initiative.
150 cross-sector experts, innovators and policymakers will convene today at the National Press Club in Washington, D.C. to drive awareness of the opportunities for collaboration at the nexus of food and health
Washington, D.C. USA, May 13, 2015 /3BL Media/ --- The Future of Food: The Nexus of Food and Health summit—co-hosted by global affairs magazine Diplomatic Courier and Mars, Incorporated—will look at the vital role collaboration across sectors can play in sustainably addressing the world’s most pressing food and health challenges.